Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection
Open accessAbstract
BACKGROUND & AIMS: Fecal microbiota transplantation (FMT) is recommended for treatment of recurrent Clostridium difficile infection (rCDI). We performed a single-center randomized trial to compare the effects of FMT with those of fidaxomicin and vancomycin. METHODS: We studied consecutive adults with rCDI seen at a gastroenterology clinic in Denmark from April 5, 2016 through June 10, 2018. Patients were randomly assigned to a group that received FMT, applied by colonoscopy or nasojejunal tube, after 4-10 days of vancomycin (125 mg 4 times daily; FMTv; n = 24), 10 days of fidaxomicin (200 mg twice daily; n = 24), or 10 days of vancomycin (125 mg 4 times daily; n = 16). Patients who had rCDI after this course of treatment and patients who could not be randomly assigned to groups were offered rescue FMTv. The primary outcome was combined clinical resolution and a negative result from a polymerase chain reaction test for Clostridium difficile (CD) toxin 8 weeks after the allocated treatment. Secondary end points included clinical resolution at week 8. RESULTS: All 64 patients received their assigned treatment. The combination of clinical resolution and negative results from the test for CD were observed in 17 patients given FMTv (71%), 8 patients given fidaxomicin (33%), and 3 patients given vancomycin (19%; P = .009 for FMTv vs fidaxomicin; P = .001 for FMTv vs vancomycin; P = .31 for fidaxomicin vs vancomycin). Clinical resolution was observed in 22 patients given FMTv (92%), 10 patients given fidaxomicin (42%), and 3 patients given vancomycin (19%; P = .0002; P < .0001; P = .13). Results did not differ significantly between patients who received FMTv as their initial therapy and patients who received rescue FMTv. There was 1 serious adverse event that might have been related to FMTv. CONCLUSIONS: In a randomized trial of patients with rCDI, we found the FMTv combination superior to fidaxomicin or vancomycin based on end points of clinical and microbiological resolution or clinical resolution alone. ClinicalTrials.gov, number NCT02743234; EudraCT, j.no 2015-003004-24.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FMT has proven to be a reliable therapeutic alternative to the antibiotics vancomycin and fidaxomicin for rCDI.
“has proven to be a reliable therapeutic alternative to the antibiotics vancomycin 6,7 and fidaxomicin. 8”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL
Clopper, C. J., & Pearson, E. S. (1934) · Biometrika · doi:10.1093/biomet/26.4.404 · Cited by 5,106 · see citing works
Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i>
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · see citing works
Fundamentals of Clinical Trials
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · doi:10.1007/978-3-319-18539-2 · Cited by 2,237 · see citing works
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A. L., Golan, Y., Gorbach, S. L., Sears, P. S., & Shue, Y. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,580 · see citing works
Clostridium difficile Infection
Leffler, D. A., & LaMont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,461 · see citing works
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,212 · see citing works
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207 · see citing works
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., BENTHEM, B. H. B. V., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,014 · see citing works
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 798 · see citing works
Documenta Geigy; scientific tables.
(1963) · JAMA · doi:10.1001/jama.1963.03700140139041 · Cited by 778 · see citing works
Cornely, O. A., Crook, D. W., Esposito, R., Poirier, A., Somero, M. S., Weiss, K., Sears, P. S., & Gorbach, S. L. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70374-7 · Cited by 755 · see citing works
Brandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., & Surawicz, C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.60 · Cited by 672 · see citing works
Lee, C. H., Steiner, T., Petrof, E. O., Smieja, M., Roscoe, D., Nematallah, A., Weese, J. S., Collins, S., Moayyedi, P., Crowther, M., et al. (2016) · JAMA · doi:10.1001/jama.2015.18098 · Cited by 627 · see citing works
Kelly, C. R., Khoruts, A., Staley, C. M., Sadowsky, M. J., Abd, M., Alani, M. A., Bakow, B. R., Curran, P., McKenney, J. L., Tisch, A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0271 · Cited by 613 · see citing works
Cammarota, G., Masucci, L., Ianiro, G., Bibbò, S., Dinoi, G., Costamagna, G., Sanguinetti, M., & Gasbarrini, A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13144 · Cited by 558 · see citing works
Youngster, I., Sauk, J., Pindar, C., Wilson, R. G., Kaplan, J. L., Smith, M. B., Alm, E. J., Gevers, D., Russell, G. H., & Hohmann, E. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu135 · Cited by 467 · see citing works
Diagnosis and Treatment ofClostridium difficilein Adults
Bagdasarian, N., Rao, K. K., & Malani, P. (2015) · JAMA · doi:10.1001/jama.2014.17103 · Cited by 445 · see citing works
Increase inClostridium difficile–related Mortality Rates, United States, 1999–2004
Redelings, M. D., Sorvillo, F. J., & Mascola, L. (2007) · Emerging infectious diseases · doi:10.3201/eid1309.061116 · Cited by 431 · see citing works
Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000046 · Cited by 428 · see citing works
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., & Wang, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161174 · Cited by 410 · see citing works
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
Cornely, O. A., Miller, M. A., Louie, T., Crook, D. W., & Gorbach, S. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis462 · Cited by 401 · see citing works
Harmonisation in Pharmacovigilance
Edwards, I. R., & Biriell, C. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00001 · Cited by 396 · see citing works
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
Garey, K. W., Sethi, S., Yadav, Y., & DuPont, H. L. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.08.012 · Cited by 375 · see citing works
Fecal Microbiota Transplantation for Clostridium difficile Infection
Drekonja, D. M., Reich, J., Gezahegn, S., Greer, N. L., Shaukat, A., MacDonald, R. H., Rutks, I., & Wilt, T. J. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2693 · Cited by 371 · see citing works
Mattila, E., Uusitalo–Seppälä, R., Wuorela, M., Lehtola, L., Nurmi, H., Ristikankare, M., Moilanen, V., Salminen, K., Seppälä, M., Mattila, P. S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.037 · Cited by 371 · see citing works
Fundamentals of Clinical Trials
Rhoads, G. G. (1986) · JAMA · doi:10.1001/jama.1986.03380080101043 · Cited by 345 · see citing works
Documenta geigy: Scientific tables
Chesley, L. C. (1964) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(64)90272-8 · Cited by 343 · see citing works
Zhang, S., Palazuelos‐Munoz, S., Balsells, E., Nair, H., Chit, A., & Kyaw, M. H. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1786-6 · Cited by 302 · see citing works
Crook, D. W., Walker, A. S., Kean, Y., Weiss, K., Cornely, O. A., Miller, M. A., Esposito, R., Louie, T., Stoesser, N. E., Young, B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis499 · Cited by 258 · see citing works
Hu, M. Y., Katchar, K., Kyne, L., Maroo, S., Tummala, S., Dreisbach, V. C., Xu, H. J., Leffler, D. A., & Kelly, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.038 · Cited by 241 · see citing works
Guery, B. P., Menichetti, F., Anttila, V.-J., Adomakoh, N., Aguado, J. M., Bisnauthsing, K. N., Georgopali, A., Goldenberg, S. D., Karas, A., Kazeem, G., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30751-x · Cited by 227 · see citing works
Fischer, M., Sipe, B. W., Cheng, Y., Phelps, E. L., Rogers, N. A., Sagi, S. V., Bohm, M. E., Xu, H., & Kassam, Z. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1273998 · Cited by 190 · see citing works
Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients
Kelly, C. R., de Leon, L., & Jasutkar, N. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318234570b · Cited by 189 · see citing works
Adverse events in faecal microbiota transplant: a review of the literature
Baxter, M., & Colville, A. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.10.024 · Cited by 186 · see citing works
Jiang, Z., Ajami, N. J., Petrosino, J. F., Jun, G., Hanis, C. L., Shah, M. S., Hochman, L. G., Ankoma‐Sey, V., DuPont, A. W., Wong, M. C., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13969 · Cited by 182 · see citing works
Ianiro, G., Masucci, L., Quaranta, G., Simonelli, C., Lopetuso, L. R., Sanguinetti, M., Gasbarrini, A., & Cammarota, G. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14816 · Cited by 152 · see citing works
Rubin, T. A., Gessert, C. E., Aas, J., & Bakken, J. (2012) · Anaerobe · doi:10.1016/j.anaerobe.2012.11.004 · Cited by 135 · see citing works
Hensgens, M. P. M., Goorhuis, A., Dekkers, O. M., BENTHEM, B. H. B. V., & Kuijper, E. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis1209 · Cited by 129 · see citing works
Costello, S. P., Tucker, E. C., LaBrooy, J. T., Schoeman, M., & Andrews, J. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ994 · Cited by 105 · see citing works
Multiple biopsy passes and the risk of complications of percutaneous liver biopsy
Chi, H., Hansen, B. E., Tang, W. Y., Schouten, J. N. L., Sprengers, D., Taimr, P., Janssen, H. L. A., & de Knegt, R. J. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000731 · Cited by 105 · see citing works
Palmer, K., Vetrano, D. L., Marengoni, A., Tummolo, A. M., Villani, E. R., Acampora, N., Bernabei, R., & Onder, G. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1049-x · Cited by 101 · see citing works
Kelly, C. R., Kunde, S. S., & Khoruts, A. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.060 · Cited by 79 · see citing works
Magee, G., Strauss, M. E., Thomas, S. M., Brown, H., Baumer, D. L., & Broderick, K. C. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.06.004 · Cited by 70 · see citing works
Jalanka, J., Hillamaa, A., Satokari, R. M., Mattila, E., Anttila, V., & Arkkila, P. E. T. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14443 · Cited by 64 · see citing works
Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance
Mullane, K. M. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313511285 · Cited by 61 · see citing works
Monnier, A. L., Duburcq, A., Zahar, J., Corvec, S., Guillard, T., Cattoir, V., Woerther, P., Fihman, V., Lalande, V., Jacquier, H., et al. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.06.017 · Cited by 55 · see citing works
Determining Mortality Rates Attributable toClostridium difficileInfection
Hota, S. S., Achonu, C., Crowcroft, N. S., Harvey, B. J., Lauwers, A. E., & Gardam, M. A. (2012) · Emerging infectious diseases · doi:10.3201/eid1802.101611 · Cited by 53 · see citing works
Faecal microbiota transplantation: establishment of a clinical application framework
Baunwall, S. M. D., Hansen, M. M., Erikstrup, C., Dahlerup, J. F., & Hvas, C. L. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000958 · Cited by 48 · see citing works
Diagnosis and Treatment of Clostridium difficile Infection
Gupta, A., Cifu, A. S., & Khanna, S. (2018) · JAMA · doi:10.1001/jama.2018.12194 · Cited by 47 · see citing works
Recruitment of feces donors among blood donors: Results from an observational cohort study
Baunwall, S. M. D., Erikstrup, C., Dinh, K. M., Lemming, L. E., Dahlerup, J. F., & Hvas, C. L. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1458179 · Cited by 44 · see citing works
Soriano, M. M., Danziger, L. H., Gerding, D. N., & Johnson, S. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu069 · Cited by 41 · see citing works
van Beurden, Y. H., Nieuwdorp, M., van de Berg, P. J. E. J., Mulder, C. J. J., & Goorhuis, A. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17690480 · Cited by 36 · see citing works
High Horn’s index score predicts poor outcomes in patients with Clostridium difficile infection
Arora, V., Kachroo, S., Ghantoji, S. S., DuPont, H. L., & Garey, K. W. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.04.027 · Cited by 35 · see citing works
A multi-center study of fidaxomicin use for Clostridium difficile infection
Shah, D. N., Chan, F. S., Kachru, N., Garcia, K. P., Balcer, H. E., Dyer, A., Emanuel, J. E., Jordan, M., Lusardi, K. T., Naymick, G., et al. (2016) · SpringerPlus · doi:10.1186/s40064-016-2825-x · Cited by 12 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Hota SS, Achonu C, Crowcroft NS, et al. Determining mortality rates attributable to Clostridium difficile infec- tion. Emerg Infect Dis 2012;18:305-307.
- Edwards IR, Biriell C. Harmonisation in pharmacovigi- lance. Drug Saf 1994;10:93-102.
- European Commission. Detailed guidance on the collec- tion, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use ('CT-3'). CELEX number 52011XC0611(01). Official Journal of the European Union, 2011.
- Bagdasarian N, Rao K, Malani PN. Diagnosis and treat- ment of Clostridium difficile in adults: a systematic re- view. JAMA 2015;313:398-408.
Cited by
Sorted by citations
van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640 · see citing works
Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319548 · Cited by 506 · see citing works
Fecal microbiota transplantation: current challenges and future landscapes
Yadegar, A., Bar‐Yoseph, H., Monaghan, T. M., Pakpour, S., Severino, A., Kuijper, E. J., Smits, W. K., Terveer, E. M., Neupane, S., Nabavi-Rad, A., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-22 · Cited by 379 · see citing works
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.020 · Cited by 331 · see citing works
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31266-8 · Cited by 358 · see citing works
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 360 · see citing works
Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F., & Hvas, C. L. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100642 · Cited by 302 · see citing works
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 301 · see citing works
Peery, A. F., Kelly, C. R., Kao, D. H., Vaughn, B. P., Lebwohl, B., Singh, S. S., Imdad, A., & Altayar, O. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.008 · Cited by 282 · see citing works
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
Liu, S., Zhao, W., Lan, P., & Mou, X. (2020) · Protein & Cell · doi:10.1007/s13238-020-00745-3 · Cited by 266 · see citing works
Challenge to the Intestinal Mucosa During Sepsis
Haußner, F., Chakraborty, S., Halbgebauer, R., & Huber-Lang, M. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00891 · Cited by 230 · see citing works
Leveraging diet to engineer the gut microbiome
Wolter, M., Grant, E. T., Boudaud, M., Steimle, A., Pereira, G. V., Martens, E. C., & Desai, M. S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00512-7 · Cited by 211 · see citing works
Fecal microbiota transplantation therapy for Parkinson's disease: A preliminary study
Xue, L.-J., Yang, X.-Z., Tong, Q., Shen, P., Ma, S.-J., Wu, S.-N., Zheng, J.-L., & Wang, H.-G. (2020) · Medicine · doi:10.1097/md.0000000000022035 · Cited by 186 · see citing works
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Jain, T., Sharma, P., Are, A. C., Vickers, S. M., & Dudeja, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622064 · Cited by 184 · see citing works
Regulation, risk and safety of Faecal Microbiota Transplant
Merrick, B., Allen, L., Masirah M Zain, N., Forbes, B., Shawcross, D. L., & Goldenberg, S. D. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100069 · Cited by 171 · see citing works
Fecal microbiota transplantation beyond Clostridioides difficile infections
Wortelboer, K., Nieuwdorp, M., & Herrema, H. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.066 · Cited by 163 · see citing works
Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
Sultan, S., El‐Mowafy, M., Elgaml, A., Ahmed, T. A., Hassan, H., & Mottawea, W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715506 · Cited by 161 · see citing works
Infections in the Elderly Critically-Ill Patients
Eşme, M., Topeli̇, A., Doğu, B. B., & Akova, M. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00118 · Cited by 157 · see citing works
Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology
Khoruts, A., Staley, C., & Sadowsky, M. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0350-4 · Cited by 155 · see citing works
Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases
Biazzo, M., & Deidda, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144119 · Cited by 166 · see citing works
Baunwall, S. M. D., Paaske, S. E., Hansen, M. M., Kelsen, J., Høyer, K. L., Rågård, N., Eriksen, L. L., Støy, S. H., Rubak, T., Damsgaard, E. M. S., et al. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(22)00276-x · Cited by 130 · see citing works
Buhaș, M. C., Gavrilaș, L. I., CANDREA, A. R., Cătinean, A., Mocan, A., Miere, D., & Tataru, A. D. (2022) · Nutrients · doi:10.3390/nu14142970 · Cited by 130 · see citing works
Delivery routes for faecal microbiota transplants: Available, anticipated and aspired
Gulati, M., Singh, S. K., Corrie, L., Kaur, I. P., & Chandwani, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104954 · Cited by 112 · see citing works
Ianiro, G., Murri, R., Sciumè, G. D., Impagnatiello, M., Masucci, L., Ford, A. C., Law, G. R., Tilg, H., Sanguinetti, M., Cauda, R., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3635 · Cited by 107 · see citing works
Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
Belvončíková, P., Marônek, M., & Gardlík, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810729 · Cited by 108 · see citing works
Clostridioides difficile: diagnosis and treatments
Guery, B. P., Galperine, T. K., & Barbut, F. (2019) · BMJ · doi:10.1136/bmj.l4609 · Cited by 106 · see citing works
Epidemiology of community-acquired and recurrent Clostridioides difficile infection
Fu, Y., Luo, Y., & Grinspan, A. M. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211016248 · Cited by 94 · see citing works
Minkoff, N. Z., Aslam, S., Medina, M., Tanner‐Smith, E. E., Zackular, J. P., Acra, S. A., Nicholson, M. R., & Imdad, A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013871.pub2 · Cited by 99 · see citing works
Nicco, C., Paule, A., Konturek, P. C., & Edeas, M. A. (2020) · Diseases · doi:10.3390/diseases8020009 · Cited by 87 · see citing works
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
Li, M., Yang, L., Mu, C., Sun, Y., Gu, Y., Chen, D., Liu, T., & Cao, H. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.038 · Cited by 87 · see citing works
Therapies to modulate gut microbiota: Past, present and future
Gupta, A., Saha, S., & Khanna, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i8.777 · Cited by 83 · see citing works
Gut Microbiota: Its Potential Roles in Pancreatic Cancer
Li, Q., Jin, M., Liu, Y., & Jin, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572492 · Cited by 84 · see citing works
Bishop, E. J., & Tiruvoipati, R. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac404 · Cited by 78 · see citing works
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yang, Y., An, Y., Dong, Y., Chu, Q., Wei, J., Wang, B., & Cao, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104967 · Cited by 79 · see citing works
Research progress on the relationship between intestinal microecology and intestinal bowel disease
Fu, Q.-H., Song, T., Ma, X., & Cui, J. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12262 · Cited by 74 · see citing works
Microbiota-mediated protection against antibiotic-resistant pathogens
Panwar, R., Sequeira, R. P., & Clarke, T. B. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00129-5 · Cited by 73 · see citing works
Liu, C. S., Monaghan, T. M., Yadegar, A., Louie, T., & Kao, D. H. (2023) · Antibiotics · doi:10.3390/antibiotics12071141 · Cited by 73 · see citing works
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
Quaranta, G., Guarnaccia, A., Fancello, G., Agrillo, C., Iannarelli, F., Sanguinetti, M., & Masucci, L. (2022) · Microorganisms · doi:10.3390/microorganisms10122424 · Cited by 71 · see citing works
Rokkas, T., Gisbert, J. P., Gasbarrini, A., Hold, G. L., Tilg, H., Malfertheiner, P., Mégraud, F., & O'Morain, C. A. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619854587 · Cited by 68 · see citing works
The role of the gut microbiota in tumor, immunity, and immunotherapy
Xie, Y., & Liu, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1410928 · Cited by 70 · see citing works
Xie, W.-R., Yang, X.-Y., Xia, H. H.-X., Wu, L.-H., & He, X.-X. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i19.3074 · Cited by 67 · see citing works
Terveer, E. M., Vendrik, K. E. W., Ooijevaar, R. E., van Lingen, E., Boeije‐Koppenol, E., van Nood, E., Goorhuis, A., Bauer, M. P., van Beurden, Y. H., Dijkgraaf, M. G. W., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620957765 · Cited by 64 · see citing works
Jain, N., Umar, T. P., Fahner, A.-F., & Ģībietis, V. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2232137 · Cited by 65 · see citing works
Huang, H., Jiang, J., Wang, X., Jiang, K., & Cao, H. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102428 · Cited by 67 · see citing works
The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
Özdirik, B., Müller, T., Wree, A., Tacke, F., & Sigal, M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136975 · Cited by 61 · see citing works
Adverse events in fecal microbiota transplantation: a systematic review and meta-analysis
Rapoport, E. A. (2022) · Annals of Gastroenterology · doi:10.20524/aog.2022.0695 · Cited by 59 · see citing works
Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
Piccioni, A., Rosa, F., Manca, F., Pignataro, G., Zanza, C., Savioli, G., Covino, M., Ojetti, V., Gasbarrini, A., Franceschi, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113323 · Cited by 62 · see citing works
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
Airola, C., Severino, A., Porcari, S., Fusco, W. G., Mullish, B. H., Gasbarrini, A., Cammarota, G., Ponziani, F. R., & Ianiro, G. (2023) · Antibiotics · doi:10.3390/antibiotics12050868 · Cited by 63 · see citing works
Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline
Kucharzik, T., Dignass, A., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengiesser, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2020) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/a-1296-3444 · Cited by 48 · see citing works
Li, J., Feng, S., Wang, Z., He, J., Zhang, Z., Zou, H., Wu, Z., Liu, X., Hong Kui, W. E. I., & Tao, S. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00403-6 · Cited by 58 · see citing works
Lemons, J. M. S., Conrad, M. A., Tanes, C., Chen, J., Friedman, E. S., Roggiani, M., Curry, D., Chau, L., Hecht, A. L., Harling, L. C., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.005 · Cited by 57 · see citing works
Updates in Treatment of Recurrent Clostridium difficile Infection
Singh, T., Bedi, P. S., Bumrah, K., Singh, J., Rai, M., & Seelam, S. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3854 · Cited by 54 · see citing works
Vaughn, B. P., Fischer, M., Kelly, C. R., Allegretti, J. R., Graiziger, C. T., Thomas, J., McClure, E. L., Kabage, A. J., & Khoruts, A. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.09.008 · Cited by 52 · see citing works
Rode, A. A., Chehri, M., Krogsgaard, L. R., Heno, K. K., Svendsen, A. T., Ribberholt, I., Helms, M., Engberg, J., Schønning, K., Tvede, M., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16309 · Cited by 51 · see citing works
Karjalainen, E. K., Renkonen‐Sinisalo, L., Satokari, R. M., Mustonen, H. K., Ristimaki, A. P., Arkkila, P. E. T., & Lepistö, A. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab001 · Cited by 51 · see citing works
Long-distance microbial mechanisms impacting cancer immunosurveillance
Zitvogel, L., Fidelle, M., & Kroemer, G. (2024) · Immunity · doi:10.1016/j.immuni.2024.07.020 · Cited by 51 · see citing works
Fecal microbiota transplantation: great potential with many challenges
Kellermayer, R. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.05.10 · Cited by 49 · see citing works
Update on Treatment of Clostridioides difficile Infection
Cho, J. M., Pardi, D. S., & Khanna, S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.08.006 · Cited by 48 · see citing works
Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
Hetta, . F., Ramadan, Y. N., Alharbi, A. A., Alsharif, S. M., Alkindy, T. T., Alkhamali, A., Albalawi, A. S., & El‐Amin, H. (2024) · Immuno · doi:10.3390/immuno4040026 · Cited by 50 · see citing works
Evolution of fecal microbiota transplantation in methodology and ethical issues
Zhang, F., Zhang, T., Zhu, H., & Borody, T. J. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.004 · Cited by 45 · see citing works
Improving Risk–Benefit in Faecal Transplantation through Microbiome Screening
Papanicolas, L. E., Gordon, D., Wesselingh, S. L., & Rogers, G. B. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2019.12.009 · Cited by 46 · see citing works
Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment
Spigaglia, P. (2024) · Pathogens · doi:10.3390/pathogens13080646 · Cited by 51 · see citing works
Wang, Z., Tian, L., Liu, L., Xie, J., Tang, F., Pi, Y., Zhong, Y., He, Z., Zhang, W., & Zheng, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107663 · Cited by 45 · see citing works
The blood-brain barrier, a key bridge to treat neurodegenerative diseases
Hang, Z., Zhou, L., Xing, C., Wen, Y., & Du, H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102070 · Cited by 45 · see citing works
Fecal microbiota transplantation (FMT) for C. difficile infection, just say ‘No’
Tan, X., & Johnson, S. (2019) · Anaerobe · doi:10.1016/j.anaerobe.2019.102092 · Cited by 42 · see citing works
Wei, S., Bahl, M. I., Baunwall, S. M. D., Dahlerup, J. F., Hvas, C. L., & Licht, T. R. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2084306 · Cited by 43 · see citing works
Dissecting mechanisms of fecal microbiota transplantation efficacy in disease
Andary, C. M., Al, K. F., Chmiel, J. A., Gibbons, S., Daisley, B. A., Parvathy, S. N., Vareki, S. M., Bowdish, D. M. E., Silverman, M., & Burton, J. P. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.005 · Cited by 42 · see citing works
The Evolving Landscape of Fecal Microbial Transplantation
Shao, T., Hsu, R., Hacein-Bey, C., Zhang, W., Gao, L., Kurth, M. J., Zhao, H., Shuai, Z., & Leung, P. S. C. (2023) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-023-08958-0 · Cited by 42 · see citing works
Drekonja, D. M., Shaukat, A., Huang, Y., Zhang, J. H., Reinink, A. R., Nugent, S. M., Dominitz, J. A., Davis‐Karim, A., Gerding, D. N., & Kyriakides, T. C. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae467 · Cited by 41 · see citing works
Baunwall, S. M. D., Dahlerup, J. F., Engberg, J., Erikstrup, C., Helms, M., Juel, M. A., Kjeldsen, J., Nielsen, H. L., Nilsson, A. C., Rode, A. A., et al. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1922749 · Cited by 45 · see citing works
Cold, F., Baunwall, S. M. D., Dahlerup, J. F., Petersen, A. M., Hvas, C. L., & Hansen, L. H. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211041004 · Cited by 41 · see citing works
Polívková, S., Krůtová, M., Čapek, V., Sýkorová, B., & Beneš, J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.004 · Cited by 40 · see citing works
Microbiome Engineering: A Promising Approach to Improve Coral Health
Li, J., Yang, Q., Dong, J., Sweet, M. J., Zhang, Y., Liu, C., Zhang, Y., Tang, X., Zhang, W., & Zhang, S. (2022) · Engineering · doi:10.1016/j.eng.2022.07.010 · Cited by 39 · see citing works
Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.03.001 · Cited by 41 · see citing works
Cutone, A., Ianiro, G., Lepanto, M. S., Rosa, L., Valenti, P., di Patti, M. C. B., & Musci, G. (2020) · Cancers · doi:10.3390/cancers12123806 · Cited by 39 · see citing works
Intestinal Microbiota—A Promising Target for Antiviral Therapy?
Yang, M., Yang, Y., He, Q., Zhu, P., Liu, M., Xu, J., & Zhao, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676232 · Cited by 39 · see citing works
Peñamarín, C., & Frabetti, C. (1990) · Dialnet (Universidad de la Rioja) · Cited by 39 · see citing works
Bacteriophage-mediated manipulations of microbiota in gastrointestinal diseases
Haddad, L. E., Mendoza, J. F., & Jobin, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1055427 · Cited by 40 · see citing works
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2)
Kucharzik, T., Dignass, A., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengiesser, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2024) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/a-2271-0994 · Cited by 37 · see citing works
Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship
Tan, G. S. E., Tay, H. L., Tan, S. H., Lee, T. H., Ng, T. M., & Lye, D. C. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01458-z · Cited by 37 · see citing works
Proton Pump Inhibitors and Oral–Gut Microbiota: From Mechanism to Clinical Significance
Zhang, X., Li, Q., Xia, S., He, Y., Liu, Y., Yang, J., & Xiao, X. (2024) · Biomedicines · doi:10.3390/biomedicines12102271 · Cited by 37 · see citing works
Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331550 · Cited by 35 · see citing works
Bretto, E., Caviglia, G. P., Saracco, G. M., Bugianesi, E., & Ribaldone, D. G. (2025) · Biomedicines · doi:10.3390/biomedicines13081807 · Cited by 38 · see citing works
Xie, J., Yao, M., Lu, Y., Yu, M., Han, S., McClements, D. J., Xiao, H., & Li, L. (2021) · Food & Function · doi:10.1039/d0fo03235b · Cited by 34 · see citing works
Fecal microbiota transplantation for recurrent Clostridioides difficile , safety, and pitfalls
Sandhu, A., & Chopra, T. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211053105 · Cited by 38 · see citing works
Yau, Y. K., Su, Q., Xu, Z., Tang, W., Ching, J. Y. L., Mak, J. W. Y., Cheung, C. P., Fung, M., Ip, M., Chan, P. K. S., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17703 · Cited by 34 · see citing works
Allegretti, J. R., Khanna, S., Mullish, B. H., & Feuerstadt, P. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.004 · Cited by 34 · see citing works
The Route to Palatable Fecal Microbiota Transplantation
Fadda, H. M. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-1637-z · Cited by 33 · see citing works
Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 34 · see citing works
Manthey, C. F., Epple, H., Keller, K., Lübbert, C., Posovszky, C., Ramharter, M., Reuken, P. A., Suerbaum, S., Vehreschild, M. J. G. T., Weinke, T., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2240-1428 · Cited by 32 · see citing works
Adverse events of fecal microbiota transplantation: a metaanalysis of high-quality studies
Michailidis, L. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0655 · Cited by 34 · see citing works
Update on microbiota-derived therapies for recurrent Clostridioides difficile infections
Benech, N., Barbut, F., Fitzpatrick, F., Krůtová, M., Davies, K., Druart, C., Cordaillat‐Simmons, M., Heritage, J. C., Guery, B. P., & Kuijper, E. J. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.12.007 · Cited by 31 · see citing works
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Zhou, Y., Xu, H., Huang, H., Li, Y., Chen, H., He, J., Du, Y., Chen, Y., Zhou, Y., & Nie, Y. (2019) · BioMed Research International · doi:10.1155/2019/3469754 · Cited by 32 · see citing works
Zou, B., Liu, S., Li, X., He, J., Dong, C., Ruan, M.-L., Xu, L., Bai, T., Huang, Z., & Shu, S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.964154 · Cited by 31 · see citing works
Fecal Microbiota Transplantation in Gastrointestinal and Extraintestinal Disorders
Ianiro, G., Segal, J. P., Mullish, B. H., Quraishi, M. N., Porcari, S., Fabiani, G., Gasbarrini, A., & Cammarota, G. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0061 · Cited by 31 · see citing works
Boucher, L., Leduc, L., Leclère, M., & Costa, M. (2024) · Animals · doi:10.3390/ani14050758 · Cited by 34 · see citing works
Kucharzik, T., Dignass, A., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengiesser, K., Kienle, P., Langhorst, J., Lügering, A., et al. (2023) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/a-2060-0935 · Cited by 24 · see citing works
Wang, Y., Hunt, A., Danziger, L. H., & Drwiega, E. N. (2024) · Antibiotics · doi:10.3390/antibiotics13050436 · Cited by 29 · see citing works
New Therapeutic Targets in Autoimmune Cholangiopathies
Gerussi, A., Luca, M. D., Cristoferi, L., Ronca, V., Mancuso, C., Milani, C., D’Amato, D., O'Donnell, S. E., Carbone, M., & Invernizzi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00117 · Cited by 29 · see citing works
Aby, E. S., Vaughn, B. P., Enns, E. A., & Rajasingham, R. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac207 · Cited by 28 · see citing works
- Authors
- Hvas, C. L., Dahl Jørgensen, S. M., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C., & Dahlerup, J. F.
- Affiliations
- Aarhus University Hospital (DK)
- Corresponding author
- Hvas, Christian Lodberg
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 156
- Issue
- 5
- Pages
- 1324-1332.e3
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2907954911
- Cited by
- 390
- References
- 54
- Citations by year
- 2026: 36 · 2025: 44 · 2024: 58 · 2023: 58 · 2022: 57 · 2021: 46 · 2020: 57 · 2019: 33
- FWCI
- 36.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gastroenterology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Aalborg Universitet
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, recurrent Clostridium difficile infection, fidaxomicin, vancomycin, clinical resolution, treatment comparison, adverse events, Clostridium difficile infection
- MeSH terms
- Fecal Microbiota Transplantation, Fidaxomicin, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Clostridium Infections, Denmark, Female, Humans, Male, Middle Aged, Recurrence, Remission Induction, Time Factors, Vancomycin, Clostridioides difficile, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
